These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3715414)

  • 1. The NIMH-DIS in the assessment of DSM-III schizophrenic disorder.
    Escobar JI; Randolph ET; Asamen J; Karno M
    Schizophr Bull; 1986; 12(2):187-94. PubMed ID: 3715414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnicity and reporting of schizophrenic symptoms.
    Randolph ET; Escobar JI; Paz DH; Forsythe AB
    J Nerv Ment Dis; 1985 Jun; 173(6):332-40. PubMed ID: 3998718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome.
    Tien AY; Eaton WW
    Arch Gen Psychiatry; 1992 Jan; 49(1):37-46. PubMed ID: 1728250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delusions and hallucinations in schizophrenic patients.
    de Leon J; Cuesta MJ; Peralta V
    Psychopathology; 1993; 26(5-6):286-91. PubMed ID: 8190849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of two interview schedules. The Schedule for Affective Disorders and Schizophrenia-Lifetime and the National Institute for Mental Health Diagnostic Interview Schedule.
    Hesselbrock V; Stabenau J; Hesselbrock M; Mirkin P; Meyer R
    Arch Gen Psychiatry; 1982 Jun; 39(6):674-7. PubMed ID: 7092500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest reliability of a standardized psychiatric interview (DIS/CIDI).
    Semler G; Wittchen HU; Joschke K; Zaudig M; von Geiso T; Kaiser S; von Cranach M; Pfister H
    Eur Arch Psychiatry Neurol Sci; 1987; 236(4):214-22. PubMed ID: 3582430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures.
    Vares M; Ekholm A; Sedvall GC; Hall H; Jönsson EG
    Psychopathology; 2006; 39(6):286-95. PubMed ID: 16960467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspiciousness and alcohol use disorders in schizophrenia.
    Messias E; Bienvenu OJ
    J Nerv Ment Dis; 2003 Jun; 191(6):387-90. PubMed ID: 12826920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.
    Tibbo P; Swainson J; Chue P; LeMelledo JM
    Depress Anxiety; 2003; 17(2):65-72. PubMed ID: 12621594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedural validity of standardized symptom questions for the assessment of psychotic symptoms--a comparison of the DIS with two clinical methods.
    Spengler PA; Wittchen HU
    Compr Psychiatry; 1988; 29(3):309-22. PubMed ID: 3378418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive compulsive disorder with psychotic features.
    Eisen JL; Rasmussen SA
    J Clin Psychiatry; 1993 Oct; 54(10):373-9. PubMed ID: 8262879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood trauma.
    Kingdon DG; Ashcroft K; Bhandari B; Gleeson S; Warikoo N; Symons M; Taylor L; Lucas E; Mahendra R; Ghosh S; Mason A; Badrakalimuthu R; Hepworth C; Read J; Mehta R
    J Nerv Ment Dis; 2010 Jun; 198(6):399-403. PubMed ID: 20531117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample.
    Hasin DS; Greenstein E; Aivadyan C; Stohl M; Aharonovich E; Saha T; Goldstein R; Nunes EV; Jung J; Zhang H; Grant BF
    Drug Alcohol Depend; 2015 Mar; 148():40-6. PubMed ID: 25604321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The course of psychosis in early phases of schizophrenia.
    Harrow M; Carone BJ; Westermeyer JF
    Am J Psychiatry; 1985 Jun; 142(6):702-7. PubMed ID: 4003589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NIMH diagnostic interview schedule modified to record current mental status.
    Von Korff MR; Anthony JC
    J Affect Disord; 1982 Dec; 4(4):365-71. PubMed ID: 6298294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime psychotic symptoms assessed with the DIS.
    Pulver AE; Carpenter WT
    Schizophr Bull; 1983; 9(3):377-82. PubMed ID: 6622995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the Diagnostic Interview Schedule and clinical diagnosis.
    Erdman HP; Klein MH; Greist JH; Bass SM; Bires JK; Machtinger PE
    Am J Psychiatry; 1987 Nov; 144(11):1477-80. PubMed ID: 3674231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlates of olfactory hallucinations in schizophrenia.
    Langdon R; McGuire J; Stevenson R; Catts SV
    Br J Clin Psychol; 2011 Jun; 50(2):145-63. PubMed ID: 21545448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.